chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Fatigue, Grip strength decreased, Rhinorrhoea
Clinical narrative: runny nose; Light Arthralgia, upper back/shoulders, progressing to arms, wrists, hands; Fatigue; unable to grip and hold things w/ hands; sleeping 10 h; All sxs (Symptoms) w/ worsening progression; This is a spontaneous report from a contactable Nurse. This 53-year-old female Nurse (patient) reported that.  A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EK9231), dose 1 via an unspecified route of administration, administered in Arm Left on 26Jan2021 12:30 as dose 1, single for covid-19 immunisation. Medical history included ewing's sarcoma from an unknown date and unknown if ongoing as a teen. Concomitant medication included omeprazole 20 mg taken for an unspecified indication, start and stop date were not reported; amlodipine 2.5 mg taken for an unspecified indication, start and stop date were not reported. It was Unknown if patient had COVID prior vaccination. No COVID tested post vaccination. No other vaccine in four weeks. Patient was not pregnant at the time of vaccination. It was reported that patient experienced Day 1: constant runny nose. 3d after dose 1: 5pm: runny nose, Light Arthralgia, upper back/shoulders, progressing to arms, wrists, hands. Fatigue. All sxs (Symptoms) w/ worsening progression w/i 2h, unable to grip and hold things w/ hands, in bed by 7 pm and sleeping 10 h. This occurs daily at the same time (5p). Upon awakening the following am, I am back to my normal self / feeling well. It was reported that patient received treatment: Ibuprofen- No relief of sxs (Symptoms). The outcome of event all sxs (symptoms) w/ worsening progression was unknown and outcome of al other events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: runny nose; Light Arthralgia, upper back/shoulders, progressing to arms, wrists, hands; Fatigue; unable to grip and hold things w/ hands; sleeping 10 h; All sxs (Symptoms) w/ worsening progression; This is a spontaneous report from a contactable Nurse. This 53-year-old female Nurse (patient) reported that.  A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EK9231), dose 1 via an unspecified route of administration, administered in Arm Left on 26Jan2021 12:30 as dose 1, single for covid-19 immunisation. Medical history included ewing's sarcoma from an unknown date and unknown if ongoing as a teen. Concomitant medication included omeprazole 20 mg taken for an unspecified indication, start and stop date were not reported; amlodipine 2.5 mg taken for an unspecified indication, start and stop date were not reported. It was Unknown if patient had COVID prior vaccination. No COVID tested post vaccination. No other vaccine in four weeks. Patient was not pregnant at the time of vaccination. It was reported that patient experienced Day 1: constant runny nose. 3d after dose 1: 5pm: runny nose, Light Arthralgia, upper back/shoulders, progressing to arms, wrists, hands. Fatigue. All sxs (Symptoms) w/ worsening progression w/i 2h, unable to grip and hold things w/ hands, in bed by 7 pm and sleeping 10 h. This occurs daily at the same time (5p). Upon awakening the following am, I am back to my normal self / feeling well. It was reported that patient received treatment: Ibuprofen- No relief of sxs (Symptoms). The outcome of event all sxs (symptoms) w/ worsening progression was unknown and outcome of al other events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Hypersensitivity, Pain in extremity, Rhinorrhoea, Sinusitis
Clinical narrative: itchy eyes; I started with sneezing and drippy nose; Sore arm; I started with sneezing and drippy nose; It's just like sinus and allergy; It's just like sinus and allergy; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6198, UPC, NDC number and Expiry date: Unknown), via an unspecified route of administration on 26Feb2021 as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included allergy to pollen and asthma from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient got the first dose of the Pfizer COVID-19 vaccine on Friday morning (26Feb2021). Yesterday (27Feb2021), patient started to have adverse events like itch eyes, runny nose and drippy nose, and sneezing. The patient was fine with the sore arm. The patient said this allergic reaction maybe attributed to her allergy to pollen. The patient said other than the reactions patient mentioned, she felt fine, patient had no headache, etc. The patient mentioned her reaction got worse this morning (28Feb2021). The patient wanted to know if it was ok to take Claritin or other anti-allergy medications. The patient wanted to manage her reaction because it might flare up and the patient might have trouble because patient also has asthma. The patient had allergies anyways like with pollen going on and on now. The patient just wants to make sure because patient got up this morning and it worst. The patient does not have any other symptoms, there was no fever, and there was no pain, nothing like that. It was just like sinus and allergy. The patient just wants to make sure if it was okay patient had that. The patient did not take any Tylenol for the soreness for arm, the patient has not taken anything like that. I just want to make sure that it is okay to take maybe Zyrtec or Claritin, something like that. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: itchy eyes; I started with sneezing and drippy nose; Sore arm; I started with sneezing and drippy nose; It's just like sinus and allergy; It's just like sinus and allergy; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6198, UPC, NDC number and Expiry date: Unknown), via an unspecified route of administration on 26Feb2021 as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included allergy to pollen and asthma from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient got the first dose of the Pfizer COVID-19 vaccine on Friday morning (26Feb2021). Yesterday (27Feb2021), patient started to have adverse events like itch eyes, runny nose and drippy nose, and sneezing. The patient was fine with the sore arm. The patient said this allergic reaction maybe attributed to her allergy to pollen. The patient said other than the reactions patient mentioned, she felt fine, patient had no headache, etc. The patient mentioned her reaction got worse this morning (28Feb2021). The patient wanted to know if it was ok to take Claritin or other anti-allergy medications. The patient wanted to manage her reaction because it might flare up and the patient might have trouble because patient also has asthma. The patient had allergies anyways like with pollen going on and on now. The patient just wants to make sure because patient got up this morning and it worst. The patient does not have any other symptoms, there was no fever, and there was no pain, nothing like that. It was just like sinus and allergy. The patient just wants to make sure if it was okay patient had that. The patient did not take any Tylenol for the soreness for arm, the patient has not taken anything like that. I just want to make sure that it is okay to take maybe Zyrtec or Claritin, something like that. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Disorientation, Fatigue, Influenza like illness, Pain
Clinical narrative: disoriented; flu-like symptoms; Tired; weak; achey; Low-grade fever; This is a spontaneous report from a contactable consumer (patient).  A 77-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 at 10:15 (at the age of 77-years-old) as dose 2, single for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and psoriasis. Patient had no known allergies. The patient received no other vaccine in four weeks. Concomitant medication included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY ELLIPTA).  Historical vaccine included bnt162b2 (Batch/Lot Number: not reported) on 30Jan2021 at 12:00 pm as dose 1 in Left arm for covid-19 immunisation. On 21Feb2021, the patient experienced disoriented, flu-like symptoms, tired, weak, achey and low-grade fever. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 26Feb2021. Facility type vaccine was a school or Health Clinic. Treatment was given for the events. The patient was not covid prior vaccination. The patient tested for covid post vaccination. Outcome of the events were not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: disoriented; flu-like symptoms; Tired; weak; achey; Low-grade fever; This is a spontaneous report from a contactable consumer (patient).  A 77-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 at 10:15 (at the age of 77-years-old) as dose 2, single for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and psoriasis. Patient had no known allergies. The patient received no other vaccine in four weeks. Concomitant medication included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY ELLIPTA).  Historical vaccine included bnt162b2 (Batch/Lot Number: not reported) on 30Jan2021 at 12:00 pm as dose 1 in Left arm for covid-19 immunisation. On 21Feb2021, the patient experienced disoriented, flu-like symptoms, tired, weak, achey and low-grade fever. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 26Feb2021. Facility type vaccine was a school or Health Clinic. Treatment was given for the events. The patient was not covid prior vaccination. The patient tested for covid post vaccination. Outcome of the events were not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypotonia
Clinical narrative: dizziness; her arm became floppy; This is a spontaneous report from a contactable consumer or other non hcp (patient) via Pfizer-sponsored program. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 17Feb2021 (last Wednesday) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. That evening, she experienced dizziness. The dizziness continued until it is hard for her to do anything. She also mentioned her arm became floppy. On 17Feb2021 at evening, the patient experienced dizziness which continued until it is hard for her to do anything and also her arm became floppy. The outcome of the events was unknown.   Information about Lot/Batch number has been requested.   Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Muscular weakness, Somnolence
Clinical narrative: dizziness; her arm became floppy; This is a spontaneous report from a contactable consumer or other non hcp (patient) via Pfizer-sponsored program. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 17Feb2021 (last Wednesday) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. That evening, she experienced dizziness. The dizziness continued until it is hard for her to do anything. She also mentioned her arm became floppy. On 17Feb2021 at evening, the patient experienced dizziness which continued until it is hard for her to do anything and also her arm became floppy. The outcome of the events was unknown.   Information about Lot/Batch number has been requested.   Follow-up attempts completed. No further information expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Chills, Dizziness, Headache
Clinical narrative: Very sore left arm - difficult movement; Very sore left arm - difficult movement; Sore joints; Achy muscles; fever; chills; anxiety; insomnia; malaise; mild nausea; dizziness; headache; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6200, Expiration Date: not reported), via an unspecified route of administration in left arm on 27Feb2021 07:30 as dose 2, single for COVID-19 immunization (at the age of 44-year-old). Medical history included hypertension, anxiety, other managed conditions and allergies to erythromycin. Patient did not receive other vaccine in four weeks. Patient had numerous prescriptions in two weeks. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration in left arm on 06Feb2021 11:30 as dose 1, single for COVID-19 immunization. Patient had no covid prior vaccination and was not covid tested post vaccination. The patient experienced very sore left arm - difficult movement, sore joints, achy muscles, fever, chills, anxiety, insomnia, malaise, mild nausea, dizziness, headache on 27Feb2021 14:00. All symptoms began to resolve and decrease after 24 hours, though, some muscle aches and headache mildly remain. The patient did not receive treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Movement disorder, Myalgia, Nausea
Clinical narrative: Very sore left arm - difficult movement; Very sore left arm - difficult movement; Sore joints; Achy muscles; fever; chills; anxiety; insomnia; malaise; mild nausea; dizziness; headache; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6200, Expiration Date: not reported), via an unspecified route of administration in left arm on 27Feb2021 07:30 as dose 2, single for COVID-19 immunization (at the age of 44-year-old). Medical history included hypertension, anxiety, other managed conditions and allergies to erythromycin. Patient did not receive other vaccine in four weeks. Patient had numerous prescriptions in two weeks. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration in left arm on 06Feb2021 11:30 as dose 1, single for COVID-19 immunization. Patient had no covid prior vaccination and was not covid tested post vaccination. The patient experienced very sore left arm - difficult movement, sore joints, achy muscles, fever, chills, anxiety, insomnia, malaise, mild nausea, dizziness, headache on 27Feb2021 14:00. All symptoms began to resolve and decrease after 24 hours, though, some muscle aches and headache mildly remain. The patient did not receive treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Very sore left arm - difficult movement; Very sore left arm - difficult movement; Sore joints; Achy muscles; fever; chills; anxiety; insomnia; malaise; mild nausea; dizziness; headache; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6200, Expiration Date: not reported), via an unspecified route of administration in left arm on 27Feb2021 07:30 as dose 2, single for COVID-19 immunization (at the age of 44-year-old). Medical history included hypertension, anxiety, other managed conditions and allergies to erythromycin. Patient did not receive other vaccine in four weeks. Patient had numerous prescriptions in two weeks. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration in left arm on 06Feb2021 11:30 as dose 1, single for COVID-19 immunization. Patient had no covid prior vaccination and was not covid tested post vaccination. The patient experienced very sore left arm - difficult movement, sore joints, achy muscles, fever, chills, anxiety, insomnia, malaise, mild nausea, dizziness, headache on 27Feb2021 14:00. All symptoms began to resolve and decrease after 24 hours, though, some muscle aches and headache mildly remain. The patient did not receive treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: she hurt her back after getting the first dose of the covid vaccine; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself) via Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number-UNKNOWN) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The reporter stated that patient hurt her back after getting the first dose of the covid vaccine on an unspecified date and patient has not had any side effects even after her second dose. The outcome of the event was unknown.  Information on lot number/batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Fatigue, Headache
Clinical narrative: Sore arm at injection site; Elevated temp 99.8; Generalised aches and pains; Headache; Fatigue; Malaise; Chills; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 23Feb2021 (at the age of 65-year-old) as dose 2, single for covid-19 immunisation. Medical history included fibromyalgia, arthritis, chronic fatigue syndrome (CFIDS), asthma, guava allergy. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported; bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide, telmisartan (TELMISARTAN HCTZ) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC) taken for an unspecified indication, start and stop date were not reported. Other medications in two weeks were reported as Prozac, Wellbutrin, Zyrtec, Telmisartan HCTZ. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 02Feb2021 13:15 (at the age of 65-year-old) as dose 1, single for covid-19 immunisation. Patient did not have covid prior vaccination and covid was not tested post vaccination. On 23Feb2021 18:15, the patient experienced, first 24-hour sore arm at injection site, elevated temp 99.8 with ibuprofen on board every 6 hours, Generalized aches and pains, headache, fatigue. Second day elevated temperature 99.8 was the highest, again with NSAID on board every 5-6 hours, malaise, chills, headache. Day 3 elevated temp with chills and malaise in the afternoon and evening. Day 4 feeling better. The patient underwent lab tests and procedures which included body temperature: elevated temp 99.8 on 23Feb2021, body temperature: elevated temp 99.8 on 24Feb2021, body temperature: elevated temp on 25Feb2021. The patient received Ibuprofen for elevated temperature as treatment. The outcome of all events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Vaccination site pain
Clinical narrative: Sore arm at injection site; Elevated temp 99.8; Generalised aches and pains; Headache; Fatigue; Malaise; Chills; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 23Feb2021 (at the age of 65-year-old) as dose 2, single for covid-19 immunisation. Medical history included fibromyalgia, arthritis, chronic fatigue syndrome (CFIDS), asthma, guava allergy. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC) taken for an unspecified indication, start and stop date were not reported; bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide, telmisartan (TELMISARTAN HCTZ) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC) taken for an unspecified indication, start and stop date were not reported. Other medications in two weeks were reported as Prozac, Wellbutrin, Zyrtec, Telmisartan HCTZ. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 02Feb2021 13:15 (at the age of 65-year-old) as dose 1, single for covid-19 immunisation. Patient did not have covid prior vaccination and covid was not tested post vaccination. On 23Feb2021 18:15, the patient experienced, first 24-hour sore arm at injection site, elevated temp 99.8 with ibuprofen on board every 6 hours, Generalized aches and pains, headache, fatigue. Second day elevated temperature 99.8 was the highest, again with NSAID on board every 5-6 hours, malaise, chills, headache. Day 3 elevated temp with chills and malaise in the afternoon and evening. Day 4 feeling better. The patient underwent lab tests and procedures which included body temperature: elevated temp 99.8 on 23Feb2021, body temperature: elevated temp 99.8 on 24Feb2021, body temperature: elevated temp on 25Feb2021. The patient received Ibuprofen for elevated temperature as treatment. The outcome of all events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anger, Axillary pain, Electric shock sensation, Musculoskeletal pain
Clinical narrative: 2 days after 2nd woke up with uncontrollable anger; upper arm ached inside bones; felt like electric wire laid against bone; shoulder blade up side of neck; This is a spontaneous report from a contactable Other HCP for herself. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 27Jan2021 09:00 (Batch/Lot Number: EL3248) as dose 2, single (age at vaccination 61-year-old) for covid-19 immunisation. Medical history included type 2 Obese, hypertension, Low Blood Platelets from an unknown date and unknown if ongoing. Concomitant medication(s) included nebivolol hydrochloride (BYSTOLIC); azilsartan kamedoxomil (EDARBI); alprazolam (ALPRAZOLAM); vitamin b complex (VITAMINE B COMPLEX); ascorbic acid (VITAMINE C); colecalciferol (VITAMINE D) taken for an unspecified indication, start and stop date were not reported. Historical vaccine information included bnt162b2 (COMIRNATY) 1st dose on 06Jan2021, administered at 10:00 AMAM, lot number EK4176 for Covid-19 Immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Jan2021 07:00, the patient experienced 2 days after 2nd woke up with uncontrollable anger, upper arm ached inside bones, felt like electric wire laid against bone, shoulder blade upside of neck. It was reported that 2 days after 2nd woke up with uncontrollable anger and upper arm ached inside bone, next week pain moved to outside bone felt like electric wire laid against bone. Pain moved up and down by 3rd week under right shoulder blade up side of neck. Started taking Tylenol Called doctor thinks maybe nerve got nicked but advise to report as possible side effect. Started taking Methylprednisolne. Pain is less but still aches every day. Can't sleep. Pain still moving around now going around to arm pit. The patient underwent lab tests and procedures which included platelet count: low on an unknown date. Therapeutic measures were taken as a result of events includes Tylenol and Methylprednisolne. The outcome for all events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cough, Fatigue, Nausea, Throat irritation
Clinical narrative: my throat started burning; Coughing; Horrible stomach pain; Nauseous; very very tired; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 42-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 11:45 (Age at vaccination: 42-years-old) as single dose for covid-19 immunization. Medical history included Crohns disease from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included first dose of Covid-19 vaccine in Left arm on 06Feb2021 11:30 (Age at vaccination: 42-years-old) for covid-19 immunization. Patient did not receive any other vaccine in four weeks. Other medications in two weeks was reported as yes. Patient was not diagnosed with covid prior to vaccination. Known allergies was reported as yes. It was reported that on 27Feb2021 12:00 At the time of receiving the vaccine her throat started burning and she was coughing uncontrollably. That went away after about 10 minutes. 12 hours later she began to get very nauseous and have horrible stomach pain. she also very very tired. Since the vaccination patient was not tested for covid. Patient did not received any treatment for the events. Outcome for the events nauseous, horrible stomach pain and very very tired was reported as not resolved and for remaining events outcome was reported as resolved on 27Feb2021.  No follow up attempts are needed. Information on Lot/batch cannot be requested. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: fever (99.3); Nausea; vomiting; diarrhea; fatigue; headache; This is a spontaneous report from a contactable other hcp. A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 14:45 (age at vaccination 39 years) as dose 1, single for covid-19 immunisation. Medical history included asthma, migraine. Concomitant medication(s) included melatonin (MELATONIN); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) XR 30mg; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); vitamin d nos (VITAMIN D NOS). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 23:00 the patient experienced nausea, vomiting, diarrhea, fatigue, headache, fever (99.3). The patient underwent lab tests and procedures which included body temperature: 99.3 on 28Feb2021 (fever (99.3) 36 hours after administration of vaccine). The patient did not received treatment for reported events. The outcome of event was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: fever (99.3); Nausea; vomiting; diarrhea; fatigue; headache; This is a spontaneous report from a contactable other hcp. A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 14:45 (age at vaccination 39 years) as dose 1, single for covid-19 immunisation. Medical history included asthma, migraine. Concomitant medication(s) included melatonin (MELATONIN); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) XR 30mg; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); vitamin d nos (VITAMIN D NOS). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 23:00 the patient experienced nausea, vomiting, diarrhea, fatigue, headache, fever (99.3). The patient underwent lab tests and procedures which included body temperature: 99.3 on 28Feb2021 (fever (99.3) 36 hours after administration of vaccine). The patient did not received treatment for reported events. The outcome of event was recovering.  No follow-up attempts are possible; No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: skin rash that first appeared on both ankles, then spread to feet, up the legs, back of arms and hands; This is a spontaneous report from a contactable consumer (patient). A 82-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EM9809), dose 2 via an unspecified route of administration, administered in arm left on 17Feb2021 14:00 (at the age of 82-years-old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. No other medical history. Concomitant medications included biotin, fluoxetine, indapamide, potassium and propranolol hydrochloride taken for an unspecified indication, start and stop date were not reported. Historical vaccine of BNT162B2 (lot number: EL9262) for COVID-19 immunisation on 27Jan2021 at the age of 82 year in left arm as first dose. Prior to vaccination patient was not diagnosed with covid 19 and not tested for covid since the vaccination. On 20Feb2021 10:00 the patient was experienced skin rash that first appeared on both ankles, then spread to feet, up the legs, back of arms and hands. The treatment was not received. The outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Nausea
Clinical narrative: fatigue; joint/muscle pains all over; joint/muscle pains all over; Nausea; This is a spontaneous report from a contactable consumer or other non-health care professional.   A 63-years-old non pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 19:00 (at the age of 63-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included migraines, degenerative arthritis in the neck and mild asthma from an unspecified date. The patient's concomitant medications included thyroid (ARMOUR THYROID), Lovastatin (LOVASTATIN), acetylsalicylic acid, caffeine, paracetamol Excedrin (migraine medicine) for migraine and naproxen sodium (ALEVE) for degenerative arthritis received within 2 weeks of vaccination. The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had no known allergies. On 26Feb2021, 1:00 AM the patient experienced fatigue, joint/muscle pains all over, nausea. The patient took treatment for the adverse events over the phone call to nurse practitioner. The clinical outcome of the events was recovered on an unspecified date on Feb2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache
Clinical narrative: shoulder muscle pain; Headache; Chills; Tiredness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 59-year-old non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6202), via an unspecified route of administration in arm left on 28Feb2021 at 10:00 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. The medical history of the patient included heart disease & high blood pressure. The concomitant medications of the patient included lisinopril (LISINOPRIL), rosuvastatin (ROSUVASTATIN), metoprolol (METOPROLOL), coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]) all taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 28Feb2021 at 10:00, the patient experienced shoulder muscle pain, headache, chills and tiredness. The patient received no treatment for the events. The outcome of the events was reported as resolving.  No follow up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Dizziness, Fatigue, Paraesthesia, Paraesthesia oral
Clinical narrative: Sore and very itchy Injection Site; Sore and very itchy Injection Site; Itching and Tingling around mouth and eyes; Itching and Tingling around mouth and eyes; feeling pins & Needles and Tingling all over my body; Dizzy; Tired; Sleepy; low-grade temperature; Forehead was warmer than usual; This is a spontaneous report from a contactable pharmacist (patient herself). A 55-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in left arm on 27Feb2021 13:45 (age at vaccination: 55 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included Hashimoto's, glaucoma and hazelnut allergy. Concomitant medication(s) included levothyroxine sodium tablets and brimonidine tartrate (ALPHAGAN) eye drops. On 27Feb2021 15:45, 2 hours after the vaccination, the patient was dizzy, tired, sleepy, low-grade temperature. On 27Feb2021, the patient's forehead was warmer than usual. On 28Feb2021, the patient was sore and very itchy at injection site, itching and tingling around mouth and eyes, feeling pins and needles and tingling all over her body. The patient received Hydrocortisone 1 percent Cream, Tylenol and Claritine as treatment for the adverse events. The patient did not have any other vaccine in four weeks. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. The outcome of all the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin warm, Somnolence, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Sore and very itchy Injection Site; Sore and very itchy Injection Site; Itching and Tingling around mouth and eyes; Itching and Tingling around mouth and eyes; feeling pins & Needles and Tingling all over my body; Dizzy; Tired; Sleepy; low-grade temperature; Forehead was warmer than usual; This is a spontaneous report from a contactable pharmacist (patient herself). A 55-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in left arm on 27Feb2021 13:45 (age at vaccination: 55 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included Hashimoto's, glaucoma and hazelnut allergy. Concomitant medication(s) included levothyroxine sodium tablets and brimonidine tartrate (ALPHAGAN) eye drops. On 27Feb2021 15:45, 2 hours after the vaccination, the patient was dizzy, tired, sleepy, low-grade temperature. On 27Feb2021, the patient's forehead was warmer than usual. On 28Feb2021, the patient was sore and very itchy at injection site, itching and tingling around mouth and eyes, feeling pins and needles and tingling all over her body. The patient received Hydrocortisone 1 percent Cream, Tylenol and Claritine as treatment for the adverse events. The patient did not have any other vaccine in four weeks. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. The outcome of all the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Fatigue; Malaise; chills; fever; muscle soreness; headache; joint pain; rash; This is a spontaneous report from a contactable consumer or other non hcp.     A 65-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 14:00 as single dose for covid-19 immunisation. Medical history included food allergy ongoing, known allergy eggs Concomitant medication(s) included pregabalin (LYRICA); hydrocodone bitartrate, paracetamol (NORCO); cyclobenzaprine hydrochloride (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]) duloxetine hydrochloride (CYMBALTA; meloxicam (MELOXICAM); camphor, eucalyptus spp. oil, levomenthol, Mentha spp. oil (RELI BALM). The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was Reported that, The patient experienced fatigue, malaise, chills, fever, muscle soreness, headache, joint pain, rash on 26Feb2021 16:00 with outcome of unknown.   No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rash
Clinical narrative: Fatigue; Malaise; chills; fever; muscle soreness; headache; joint pain; rash; This is a spontaneous report from a contactable consumer or other non hcp.     A 65-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 14:00 as single dose for covid-19 immunisation. Medical history included food allergy ongoing, known allergy eggs Concomitant medication(s) included pregabalin (LYRICA); hydrocodone bitartrate, paracetamol (NORCO); cyclobenzaprine hydrochloride (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]) duloxetine hydrochloride (CYMBALTA; meloxicam (MELOXICAM); camphor, eucalyptus spp. oil, levomenthol, Mentha spp. oil (RELI BALM). The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was Reported that, The patient experienced fatigue, malaise, chills, fever, muscle soreness, headache, joint pain, rash on 26Feb2021 16:00 with outcome of unknown.   No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: arm was swollen; This is a spontaneous report from a contactable pharmacist (patient). This 79-year-old male patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262; Expiration Date: 31May2021) via an unspecified route of administration, on 02Feb2021 at 8:30 as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EK5730, Expiration Date: not reported) via an unspecified route of administration, on 11Jan2021 at 12:00 as dose 1, single for COVID-19 immunisation. On an unspecified date, patient experienced arm was swollen. Caller states that he received the covid vaccine, last shot was 3 weeks ago, and he was tested for antibodies but has no antibodies. He doesn't understand this, he doesn't know if this means the vaccine was not effective. Caller adds that he does take a baby aspirin daily, and he did take baby aspirin prior to his covid vaccines. After his second dose his arm was swollen and was bothering after the vaccine and for which the doctor just told him to take 1 Advil. He took the Advil a couple hours after the second dose. He inquired if him taking his daily baby aspirin would have any effect on the antibodies and was concerned about vaccine as test came out negative for antibodies, does it mean the vaccine was not good. Caller states that his wife had the same test, same doctor, but she had antibodies. His Wife had the same dates as receiving the covid vaccine and the same lot number but she has her levels of antibodies and it was high. He states who knows maybe his wife had the virus at one point in time, he does not know, but him and his wife always repeatedly get tested for the covid virus and they are both always negative and the patient inquired should he be concerned or was that common. On 24Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative and SARS-CoV-2 test: Negative (repeatedly get tested for the covid virus and they are both always negative). The patient as a treatment received Advil for his arm swollen. Outcome of the events was unknown.  No follow up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Discolored, raised lump on left breast with tenderness; Discolored, raised lump on left breast with tenderness; Discolored, raised lump on left breast with tenderness; Fever; chills; whole body muscle aches; headache; nausea; fatigue; sore injection site; This is a spontaneous report from a non-contactable consumer or other non health care professional (patient). A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19, Solution for injection, Lot Number: EL3247, Expiry date was not reported), dose 2 via an unspecified route of administration, administered in arm right on 24Feb2021 14:45 (29-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had a known allergy to eggs, peanuts and tree nut. The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19), dose 1 via an unspecified route of administration, administered in right arm on 04Feb2021 14:45 PM (Lot Number: EL3247, Expiry date was not reported) (29-year-old at the time of vaccination) as dose 1, single for covid-19 immunization. On 25Feb2021,12:45 the patient experienced Fever, chills, whole body muscle aches, headache, nausea, fatigue, sore injection site. On 27Feb2021, the patient experienced discolored, raised lump on left breast with tenderness and she visited doctor office and emergency room for this event. The clinical outcome of the event discolored, raised lump on left breast with tenderness was not recovered and other events were unknown.  No follow-up attempts are possible. No further information is expected.